- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04688502
Effects of Wearing a Face Mask During CrossFit Exercise
May 14, 2022 updated by: Phil Chilibeck, University of Saskatchewan
The Effects of Wearing a Face Mask During COVID-19 on Performance and Intensity Markers During CrossFit Exercise
Face masks are important for prevention of transmission and contracting viruses such as COVID-19.
Gymnasiums have been identified as being susceptible to virus transmission; therefore, wearing face masks during exercise is important during pandemics.
This study will evaluate performance and physiological stress during high-intensity exercise while wearing a face mask during Crossfit exercise training.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Face masks are important for prevention of transmission and contracting viruses such as COVID-19.
Gymnasiums have been identified as being susceptible to virus transmission; therefore, wearing face masks during exercise is important during pandemics.
This study will evaluate performance and physiological stress during high-intensity exercise while wearing a face mask during Crossfit exercise training.
Twenty-four men and women will be randomly assigned to perform exercise during Crossfit exercise while wearing or not wearing a surgical face mask in a cross-over study.
Two types of exercise sessions will be assessed: A high intensity interval session and a continuous exercise session.
There will therefore be four exercise sessions evaluated in our randomized cross-over design: 1) high intensity exercise while wearing a face mask; 2) high intensity exercise with no face mask; 3) continuous exercise while wearing a face mask; 4) continuous exercise with no face mask.
Outcome variables to be assessed include exercise performance during the sessions (total repetitions for pull-ups, push-ups, and squats during continuous exercise and total repetitions for box jumps during high-intensity exercise).
Heart rate, rating of perceived exertion, and dyspnea will also be assessed throughout the exercise sessions.
Study Type
Interventional
Enrollment (Anticipated)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Philip Chilibeck, Ph.D.
- Phone Number: 1-306-343-6577
- Email: phil.chilibeck@usask.ca
Study Locations
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7N5B2
- University of Saskatchewan
-
Contact:
- Philip Chilibeck, Ph.D.
- Phone Number: 1-306-343-6577
- Email: phil.chilibeck@usask.ca
-
Contact:
- Scotty Butcher, Ph.D.
- Phone Number: 1-306-966-1711
- Email: scotty.butcher@usask.ca
-
Principal Investigator:
- Philip Chilibeck, Ph.D.
-
Principal Investigator:
- Scotty Butcher, Ph.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Experienced with CrossFit exercise training
Exclusion Criteria:
- Contra-indications to exercise as identified by a screening questionnaire (the "Get Active Questionnaire")
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: high intensity interval training wearing a face mask
|
High intensity interval training: 6 sets x 8 bench press, 10 pull-ups, and maximal number of box jumps (each set lasting 60 sec, with 4 minutes rest between sets)
|
ACTIVE_COMPARATOR: high intensity interval training wearing no face mask
|
High intensity interval training: 6 sets x 8 bench press, 10 pull-ups, and maximal number of box jumps (each set lasting 60 sec, with 4 minutes rest between sets)
|
EXPERIMENTAL: continuous exercise training wearing a face mask
|
5 pull-ups, 10 push-ups, and 15 body-weight squats, repeated for 30 minutes
|
ACTIVE_COMPARATOR: continuous exercise training wearing no face mask
|
5 pull-ups, 10 push-ups, and 15 body-weight squats, repeated for 30 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in box jumps
Time Frame: Up to 30 minutes
|
Number of box jump repetitions during high intensity exercise
|
Up to 30 minutes
|
Change from baseline in pull-up, push-up, and squat repetitions
Time Frame: Up to 30 minutes
|
Number of repetitions performed for pull-ups, push-ups, and squats
|
Up to 30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in rating of perceived exertion
Time Frame: Up to 30 minutes
|
Rating of perceived exertion on a scale of 1-10 (Modified Borg Scale), a higher score indicates a greater perceived exertion
|
Up to 30 minutes
|
Change from baseline in heart rate
Time Frame: Up to 30 minutes
|
Heart rate (beats per minute)
|
Up to 30 minutes
|
Change from baseline in dyspnea
Time Frame: Up to 30 minutes
|
Dyspnea scale (0-10), a higher score indicates increased dyspnea
|
Up to 30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Scotty Butcher, Ph.D., University of Saskatchewan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
June 11, 2022
Primary Completion (ANTICIPATED)
January 28, 2023
Study Completion (ANTICIPATED)
February 15, 2023
Study Registration Dates
First Submitted
December 24, 2020
First Submitted That Met QC Criteria
December 24, 2020
First Posted (ACTUAL)
December 30, 2020
Study Record Updates
Last Update Posted (ACTUAL)
May 17, 2022
Last Update Submitted That Met QC Criteria
May 14, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2431
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyspnea
-
Assistance Publique - Hôpitaux de ParisRecruitingDyspnea Invasive Mechanical Ventilation-associatedFrance
-
Mayo ClinicCompletedShortness of Breath | Cardiac; DyspneaUnited States
-
Qure Healthcare, LLCJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedDyspnea | Unexplained Chronic DyspneaUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedRelationship Between Dyspnea and Ventilatory VariabilityFrance
-
University of MonastirCompleted
-
University of California, Los AngelesNot yet recruitingShortness of Breath/Dyspnea
-
Assistance Publique - Hôpitaux de ParisRecruitingDyspnea and Respiratory Insufficiency in ChildrenFrance
-
Medical University of ViennaRecruitingEchocardiography | Acute DyspneaAustria
-
Intersection Medical, Inc.CompletedPulmonary Congestion | Dyspnea, | Acute Heart Failure SyndromeUnited States
-
University of CologneTeva Branded Pharmaceutical Products R&D, Inc.CompletedCancer | Dyspnea, ParoxysmalGermany
Clinical Trials on High intensity interval training
-
University of MichiganCompletedGlucose IntoleranceUnited States
-
Universidad SurcolombianaMaciste Macias; Gilberto AstaizaRecruiting
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland
-
Cairo UniversityKasr El Aini HospitalCompletedDiabetes Mellitus, Type 2Egypt
-
Universidad Santo TomasCompletedMetabolic DiseasesColombia
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Hunter College of City University of New YorkRecruiting
-
Université de SherbrookeRecruiting
-
Riphah International UniversityCompleted